3H-imidazo[1,5-d][1,2,4]triazin-4-one | 70258-50-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 3H-imidazo[1,5-d][1,2,4]triazin-4-one
• 英文别名: imidazo[1,5-d]-as-triazine-4(3H)-one；imidazo[1,5-d]-as-triazin-4(3H)-one；3H-imidazo[1,5-d][1,2,4]triazin-4-one
• CAS: 70258-50-3
• 化学式: C₅H₄N₄O
• 分子量: 136.113
• InChiKey: ONOJCVBIBBEBGK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3H-imidazo[1,5-d][1,2,4]triazin-4-one 在 溴 、 碳酸氢钠 作用下， 以 水 为溶剂， 生成 6,8-dibromo-3H-imidazo[1,5-d][1,2,4]triazin-4-one
  参考文献：
  名称：

  Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones

  摘要：

  提供了替代的咪唑[1,5-d]-嘧啶-4(3H)-酮和替代的咪唑[1,5-d]-嘧啶-4(3H)-硫酮，可用作环磷酸腺苷磷酸二酯酶的抑制剂和广谱除草剂。

  公开号：

  US04107307A1
• 作为产物：
  描述：

  ethyl N-[(E)-1H-imidazol-5-ylmethylideneamino]carbamate 、 二苯醚 以89%的产率得到
  参考文献：
  名称：

  PAUL R.; MENSCHIK J., HETEROCYCL. CHEM., 1979, 16, NO 2, 277-282

  摘要：

  DOI：

文献信息

• Method for the control of undesired plant species using
  申请人：American Cyanamid Company

  公开号：US04168964A1

  公开（公告）日：1979-09-25

  This disclosure describes herbicidal methods for the pre- and postemergence control of undesired mono- and dicotyledonous plants using substituted imidazo[1,5-d]-as-triazin-4(3H)-ones and substituted imidazo[1,5-d]-as-triazine-4(3H)-thiones.

  本公开描述了使用取代的咪唑[1,5-d]-嘧啶-4(3H)-酮和取代的咪唑[1,5-d]-嘧啶-4(3H)-硫醚来进行对不受欢迎的单子叶和双子叶植物的前期和后期除草的除草方法。
• Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
  申请人：American Cyanamid Company

  公开号：US04107307A1

  公开（公告）日：1978-08-15

  There is provided substituted imidazo[1,5-d]-as-triazine-4(3H)-ones and substituted imidazo[1,5-d]-as-triazin-4(3H)-thiones useful as inhibitors of the enzyme cyclic-AMP phosphodiesterase and as broad spectrum herbicides.

  提供了替代的咪唑[1,5-d]-嘧啶-4(3H)-酮和替代的咪唑[1,5-d]-嘧啶-4(3H)-硫酮，可用作环磷酸腺苷磷酸二酯酶的抑制剂和广谱除草剂。
• Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agents
  作者：Rolf Paul、John A. Brockman、W. A. Hallett、John W. Hanifin、M. Ernestine Tarrant、Lawrence W. Torley、Francis M. Callahan、Paul F. Fabio、Bernard D. Johnson

  DOI：10.1021/jm00149a029

  日期：1985.11

  By using inhibition of histamine release from antigen-challenged, sensitized human basophils as a means of identifying a potentially prophylactic drug for the treatment of asthma, a series of substituted imidazo[1,5-d][1,2,4]triazines were found, which were active. These compounds were prepared by treating imidazolecarboxaldehydes with excess Grignard agent and then oxidizing the resulting alcohols to ketones with Jones reagent. Pyrolysis of a mixture of ketone and methyl carbazate at 200 degrees C in diphenyl ether produced the desired imidazo[1,5-d][1,2,4]triazines. Those compounds with the greatest basophil activity were tested for in vivo activity in the mouse passive cutaneous anaphylaxis (PCA) and the guinea pig passive anaphylaxis tests. The best compounds, 1-ethyl-8-methyl-6-propylimidazo[1,5-d][1,2,4]triazin-4(3H)- one (4-17) and 1,8-dimethyl-6-propylimidazo[1,5-d][1,2,4]triazin-4-(3H)-one (4-16) were chosen for further study.
• PAUL, R.;BROCKMAN, J. A.;HALLETT, W. A.;HANIFIN, J. W.;TARRANT, M. E.;TOR+, J. MED. CHEM., 1985, 28, N 11, 1704-1716
  作者：PAUL, R.、BROCKMAN, J. A.、HALLETT, W. A.、HANIFIN, J. W.、TARRANT, M. E.、TOR+

  DOI：——

  日期：——
• US30511
  申请人：——

  公开号：——

  公开（公告）日：——